Literature DB >> 1061911

Pregnancy and von Gierke's disease.

M Farber, R A Knuppel, A Binkiewicz, R D Kennison.   

Abstract

A detailed description of the course of pregnancy in a patient with von Gierke's disease is presented. Careful dietary control together with proper management of the hematologic complications of the disease led to a successful outcome.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1061911

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


  5 in total

1.  Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries.

Authors:  Aditi I Dagli; Philip J Lee; Catherine E Correia; Christina Rodriguez; Kaustav Bhattacharya; Linda Steinkrauss; Charles A Stanley; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2010-04-13       Impact factor: 4.982

Review 2.  Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

3.  Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study.

Authors:  Annalisa Sechi; Laura Deroma; Annunziata Lapolla; Sabrina Paci; Daniela Melis; Alberto Burlina; Francesca Carubbi; Miriam Rigoldi; Maja Di Rocco
Journal:  J Inherit Metab Dis       Date:  2012-05-05       Impact factor: 4.982

4.  Pregnancies in glycogen storage disease type Ia.

Authors:  Daniëlle H J Martens; Jan Peter Rake; Martin Schwarz; Kurt Ullrich; David A Weinstein; Martin Merkel; Pieter J J Sauer; G Peter A Smit
Journal:  Am J Obstet Gynecol       Date:  2008-02-01       Impact factor: 8.661

5.  Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity.

Authors:  Maria Hoeltzenbein; Katja Stieler; Mary Panse; Evelin Wacker; Christof Schaefer
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.